• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于个体的模型评估不同人群中的 COVID-19 疫苗接种策略。

Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model.

机构信息

School of Public Health, Tel Aviv University, Tel Aviv, Israel.

Porter School of the Environment and Earth Sciences, Tel Aviv University, Tel Aviv, Israel.

出版信息

Front Public Health. 2022 Sep 15;10:966756. doi: 10.3389/fpubh.2022.966756. eCollection 2022.

DOI:10.3389/fpubh.2022.966756
PMID:36187701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9521355/
Abstract

BACKGROUND

New variants of SARS-CoV-2 are constantly discovered. Administration of COVID-19 vaccines and booster doses, combined with the application of non-pharmaceutical interventions (NPIs, is often used to prevent outbreaks of emerging variants. Such outbreak dynamics are further complicated by the population's behavior and demographic composition. Hence, realistic simulations are needed to estimate the efficiency of proposed vaccination strategies in conjunction with NPIs.

METHODS

We developed an individual-based model of COVID-19 dynamics that considers age-dependent parameters such as contact matrices, probabilities of symptomatic and severe disease, and households' age distribution. As a case study, we simulate outbreak dynamics under the demographic compositions of two Israeli cities with different household sizes and age distributions. We compare two vaccination strategies: vaccinate individuals in a currently prioritized age group, or dynamically prioritize neighborhoods with a high estimated reproductive number. Total infections and hospitalizations are used to compare the efficiency of the vaccination strategies under the two demographic structures, in conjunction with different NPIs.

RESULTS

We demonstrate the effectiveness of vaccination strategies targeting highly infected localities and of NPIs actively detecting asymptomatic infections. We further show that different optimal vaccination strategies exist for each sub-population's demographic composition and that their application is superior to a uniformly applied strategy.

CONCLUSION

Our study emphasizes the importance of tailoring vaccination strategies to subpopulations' infection rates and to the unique characteristics of their demographics (e.g., household size and age distributions). The presented simulation framework and findings can help better design future responses against the following emerging variants.

摘要

背景

不断发现 SARS-CoV-2 的新变体。结合非药物干预(NPIs)措施,常应用 COVID-19 疫苗和加强针来预防新变体的爆发。由于人群行为和人口结构的影响,这种爆发动态变得更加复杂。因此,需要进行现实模拟以评估提出的疫苗接种策略与 NPIs 结合的效率。

方法

我们开发了一种基于个体的 COVID-19 动力学模型,考虑了年龄相关的参数,如接触矩阵、有症状和严重疾病的概率以及家庭的年龄分布。作为案例研究,我们模拟了两个以色列城市在不同家庭规模和年龄分布下的爆发动态。我们比较了两种疫苗接种策略:优先接种当前年龄组的个体,或根据高估计繁殖数动态优先接种有高感染风险的社区。我们使用总感染人数和住院人数来比较两种人口结构下,不同 NPIs 下两种疫苗接种策略的效率。

结果

我们证明了针对高感染地区的疫苗接种策略和积极检测无症状感染的 NPIs 的有效性。我们进一步表明,对于每个亚人群的人口结构,存在不同的最佳疫苗接种策略,而且其应用优于统一应用的策略。

结论

我们的研究强调了根据亚人群的感染率和人口结构的独特特征(例如家庭规模和年龄分布)来制定疫苗接种策略的重要性。所提出的模拟框架和结果可以帮助更好地设计针对未来新变体的应对措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/bd4a464bd795/fpubh-10-966756-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/887f65a233e6/fpubh-10-966756-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/e5b391d866ef/fpubh-10-966756-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/f666f28ce36d/fpubh-10-966756-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/bd4a464bd795/fpubh-10-966756-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/887f65a233e6/fpubh-10-966756-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/e5b391d866ef/fpubh-10-966756-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/f666f28ce36d/fpubh-10-966756-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebec/9521355/bd4a464bd795/fpubh-10-966756-g0004.jpg

相似文献

1
Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model.使用基于个体的模型评估不同人群中的 COVID-19 疫苗接种策略。
Front Public Health. 2022 Sep 15;10:966756. doi: 10.3389/fpubh.2022.966756. eCollection 2022.
2
Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.加拿大努纳武特地区非药物干预和疫苗接种对 COVID-19 疫情的影响:加拿大免疫研究网络(CIRN)研究。
BMC Public Health. 2022 May 25;22(1):1042. doi: 10.1186/s12889-022-13432-1.
3
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
4
Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.疫苗接种作为非药物干预措施的替代方案,以预防 COVID-19 在当地的再次爆发。
Infect Dis Poverty. 2022 Mar 26;11(1):36. doi: 10.1186/s40249-022-00960-6.
5
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.接种疫苗和非药物干预措施对瑞士 SARS-CoV-2 动力学的影响。
Epidemics. 2022 Mar;38:100535. doi: 10.1016/j.epidem.2021.100535. Epub 2021 Dec 14.
6
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
7
Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.塞内加尔的非药物干预措施和 COVID-19 疫苗接种策略:一项建模研究。
BMJ Glob Health. 2022 Feb;7(2). doi: 10.1136/bmjgh-2021-007236.
8
Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories.厘清非药物干预措施和疫苗接种对欧洲 COVID-19 传播轨迹的变化影响。
Nat Commun. 2022 Jun 3;13(1):3106. doi: 10.1038/s41467-022-30897-1.
9
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
10
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.在不断变化的社会和流行病学背景下优先考虑 COVID-19 疫苗接种:一项数学建模研究。
Lancet Infect Dis. 2021 Aug;21(8):1097-1106. doi: 10.1016/S1473-3099(21)00057-8. Epub 2021 Mar 31.

引用本文的文献

1
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
2
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先级模型的系统综述
medRxiv. 2024 Mar 7:2024.03.04.24303726. doi: 10.1101/2024.03.04.24303726.
3
COVID-19 reinfections in Mexico City: implications for public health.

本文引用的文献

1
Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel-The effects of waning immunity and third vaccination dose.以色列高疫苗接种率下新冠病毒疫苗突破性感染的建模——免疫力下降和第三次疫苗接种剂量的影响
PLOS Glob Public Health. 2022 Nov 9;2(11):e0001211. doi: 10.1371/journal.pgph.0001211. eCollection 2022.
2
Strategy evaluation and optimization with an artificial society toward a Pareto optimum.利用人工社会进行策略评估与优化以实现帕累托最优。
Innovation (Camb). 2022 Jun 23;3(5):100274. doi: 10.1016/j.xinn.2022.100274. eCollection 2022 Sep 13.
3
Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence.
墨西哥城的 COVID-19 再感染:对公共卫生的影响。
Front Public Health. 2024 Feb 14;11:1321283. doi: 10.3389/fpubh.2023.1321283. eCollection 2023.
4
Risk averse reproduction numbers improve resurgence detection.风险厌恶繁殖数可提高疫情复燃检测能力。
PLoS Comput Biol. 2023 Jul 20;19(7):e1011332. doi: 10.1371/journal.pcbi.1011332. eCollection 2023 Jul.
以色列加强针运动对遏制 COVID-19 反弹的人群层面影响。
Sci Transl Med. 2022 Jun;14(647):eabn9836. doi: 10.1126/scitranslmed.abn9836. Epub 2022 Jun 1.
4
Reproduction Numbers of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants: A Systematic Review and Meta-analysis.严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 变异株的繁殖数:系统评价和荟萃分析。
Clin Infect Dis. 2022 Aug 24;75(1):e293-e295. doi: 10.1093/cid/ciac137.
5
Evaluating strategies for spatial allocation of vaccines based on risk and centrality.基于风险和中心性评估疫苗的空间分配策略。
J R Soc Interface. 2022 Feb;19(187):20210709. doi: 10.1098/rsif.2021.0709. Epub 2022 Feb 16.
6
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario.安大略省针对 COVID-19 疫苗对有症状的 SARS-CoV-2 感染和关注变种的严重后果的有效性。
Nat Microbiol. 2022 Mar;7(3):379-385. doi: 10.1038/s41564-021-01053-0. Epub 2022 Feb 7.
7
Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.全球检测人群和确诊 COVID-19 人群中无症状 SARS-CoV-2 感染比例的系统评价和荟萃分析。
JAMA Netw Open. 2021 Dec 1;4(12):e2137257. doi: 10.1001/jamanetworkopen.2021.37257.
8
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).六家以色列医院(CoVEHPI)医护人员中 BNT162b2 新冠疫苗预防 SARS-CoV-2 感染的早期效果。
Vaccine. 2022 Jan 24;40(3):512-520. doi: 10.1016/j.vaccine.2021.11.092. Epub 2021 Dec 10.
9
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.BNT162b2 mRNA COVID-19 疫苗加强针在预防以色列重症结局的有效性:一项观察性研究。
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
10
Waning Immunity after the BNT162b2 Vaccine in Israel.以色列接种 BNT162b2 疫苗后的免疫力下降。
N Engl J Med. 2021 Dec 9;385(24):e85. doi: 10.1056/NEJMoa2114228. Epub 2021 Oct 27.